Outcome incidence rates for patients initiating authorized generics (AGs) versus generics, and patients switching from brand-name products to AGs versus generics, after 1:1 propensity score matching in each database.
收藏NIAID Data Ecosystem2026-03-11 收录
数据链接:
官方服务:
资源简介:
Outcome incidence rates for patients initiating authorized generics (AGs) versus generics, and patients switching from brand-name products to AGs versus generics, after 1:1 propensity score matching in each database.
创建时间:
2019-03-13




